Clinical trial
A Multicenter, Global, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Tecfidera™ (Dimethyl Fumarate) When Used in Routine Medical Practice in the Treatment of Multiple Sclerosis (ESTEEM)
NCT02047097 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Global, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Tecfidera™ (Dimethyl Fumarate) When Used in Routine Medical Practice in the Treatment of Multiple Sclerosis (ESTEEM)
- Lead sponsor
- Biogen
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 19, 2013
- Completion date
- October 31, 2022
- Enrollment
- 5,487 (actual)
- Sites
- 468
Conditions
As the registry lists them; a condition with its own page is linked.